Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Clemens, SAC, Folegatti, PM, Emary, KRW, Weckx, LY, Ratcliff, J, Bibi, S, Verena De Almeida Mendes, A, Milan, EP, Pitella, A, Schwarzbold, AV, Sprinz, E, Aley, PK, Bonsall, D, Fraser, C, Fuskova, M, Gilbert, SC, Jenkin, D, Kelly, S, Kerridge, S, Lambe, T, Marchevsky, NG, Mujadidi, YF, Plested, E, Ramasamy, MN, Simmonds, P, Golubchik, T, Voysey, M, Pollard, AJ
Övriga upphovsmän:	AMPHEUS Project
Materialtyp:	Journal article
Språk:	English
Publicerad:	Springer Nature 2021

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Liknande verk